secwatch.observer — SEC 8-K summary
======================================

Issuer:     GE HealthCare Technologies Inc. (GEHC)
CIK:        0001932393
Form:       8-K/A
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001932393-24-000015
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GE HealthCare Q4 revenue $5.2B (+5% organic); FY24 guided adj EPS $4.20-$4.35
-----------------------------------------------------------------------------

- Q4 revenue $5.2B (+5% organic YoY); net income $403M, adj EPS $1.18; adj EBIT margin 16.1%.
- Full-year 2023 revenue $19.6B (+8% organic); adj EPS $3.93; operating cash flow $2.1B.
- Segment: Imaging +4%, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23% organic.
- FY2024 guidance: organic rev growth ~4%; adj EBIT margin 15.6%-15.9%; adj EPS $4.20-$4.35; FCF ~$1.8B.
- Repaid $850M debt in Q4 and $150M in Jan 2024; announced agreement to acquire MIM Software (no terms disclosed).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000015/0001932393-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1932393/000193239324000015/gehc-20240206.htm
  HTML page:      https://secwatch.observer/filing/0001932393-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer